Moffitt Cancer Center’s Post

View organization page for Moffitt Cancer Center, graphic

74,548 followers

Dr. Andrew Kuykendall discusses the FDA approval of momelotinib in myelofibrosis with anemia, key data from the MOMENTUM trial, and how momelotinib alters the myelofibrosis treatment paradigm on a recent OncLive podcast. Listen here ➡️ https://lnkd.in/er6cbHCE

FDA Approval Insights: Momelotinib in Myelofibrosis With Anemia

FDA Approval Insights: Momelotinib in Myelofibrosis With Anemia

onclive.com

Bonnie Labdi, PharmD, BCOP

Thought Leader; Oncology Expert

11mo

This is huge! Thanks Andrew Kuykendall!

Like
Reply

To view or add a comment, sign in

Explore topics